25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

000504 (Nanhua Bio Medicine Co Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Nanhua Bio Medicine Co Ltd together

I guess you are interested in Nanhua Bio Medicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Nanhua Bio Medicine Co Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Nanhua Bio Medicine Co Ltd’s Price Targets

I'm going to help you getting a better view of Nanhua Bio Medicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Nanhua Bio Medicine Co Ltd

I send you an email if I find something interesting about Nanhua Bio Medicine Co Ltd.

1. Quick Overview

1.1. Quick analysis of Nanhua Bio Medicine Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Nanhua Bio Medicine Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥0.83
Expected worth in 1 year
¥0.75
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
¥-0.07
Return On Investment
-0.7%

For what price can you sell your share?

Current Price per Share
¥9.67
Expected price per share
¥7.33 - ¥10.60
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Nanhua Bio Medicine Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥9.67
Intrinsic Value Per Share
¥1.66 - ¥1.93
Total Value Per Share
¥2.50 - ¥2.76

2.2. Growth of Nanhua Bio Medicine Co Ltd (5 min.)




Is Nanhua Bio Medicine Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$38.4m$26.7m$13.4m33.5%

How much money is Nanhua Bio Medicine Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$673.3k-$1m$337.5k50.1%
Net Profit Margin-13.9%-23.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Nanhua Bio Medicine Co Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#439 / 876

Most Revenue
#360 / 876

Most Profit
#218 / 876

Most Efficient
#423 / 876
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Nanhua Bio Medicine Co Ltd?

Welcome investor! Nanhua Bio Medicine Co Ltd's management wants to use your money to grow the business. In return you get a share of Nanhua Bio Medicine Co Ltd.

First you should know what it really means to hold a share of Nanhua Bio Medicine Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Nanhua Bio Medicine Co Ltd is ¥9.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nanhua Bio Medicine Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nanhua Bio Medicine Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥0.83. Based on the TTM, the Book Value Change Per Share is ¥-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nanhua Bio Medicine Co Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.020.2%0.010.1%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.020.3%0.010.1%0.000.0%0.000.0%
Usd Price Per Share1.33-1.16-1.50-1.48-1.78-2.06-
Price to Earnings Ratio-353.65--9,897.36--83.84--3,368.40--1,720.97--881.58-
Price-to-Total Gains Ratio-487.29--147.35-262.53-346.31-1,733.36-92.67-
Price to Book Ratio11.40-9.56-29.35-27.50-33.77--452.47-
Price-to-Total Gains Ratio-487.29--147.35-262.53-346.31-1,733.36-92.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.349932
Number of shares740
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (740 shares)-1.743.00
Gains per Year (740 shares)-6.9712.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-8-172102
23-17-2442014
34-25-3163026
45-33-3884038
57-42-45105150
68-50-52116162
79-58-59137174
811-67-66158186
912-75-73179198
1013-83-8019101110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%7.020.013.017.5%32.020.038.035.6%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%10.010.00.050.0%14.025.01.035.0%39.050.01.043.3%
Dividend per Share3.00.01.075.0%11.00.01.091.7%19.00.01.095.0%36.00.04.090.0%56.00.034.062.2%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%12.08.00.060.0%16.023.01.040.0%45.044.01.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Nanhua Bio Medicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.020-0.020-2%0.168-112%0.042-148%0.024-184%0.020-201%
Book Value Per Share--0.8340.872-4%0.580+44%0.583+43%0.499+67%0.350+138%
Current Ratio--1.2801.537-17%1.250+2%1.247+3%1.181+8%0.687+86%
Debt To Asset Ratio--0.5430.517+5%0.705-23%0.683-21%0.707-23%0.772-30%
Debt To Equity Ratio--1.3911.275+9%33.615-96%22.144-94%21.835-94%74.227-98%
Dividend Per Share--0.0010.003-71%0.010-90%0.005-81%0.005-79%0.006-85%
Enterprise Value--2811847676.9702435193231.850+15%3120979501.153-10%3093356643.858-9%3796042080.962-26%4556569339.116-38%
Eps---0.007-0.015+117%-0.022+226%-0.016+137%-0.011+63%-0.002-67%
Ev To Sales Ratio--31.30719.883+57%24.420+28%22.114+42%25.059+25%126.815-75%
Free Cash Flow Per Share---0.003-0.007+131%0.020-116%0.043-107%0.005-168%0.005-163%
Free Cash Flow To Equity Per Share---0.003-0.007+131%-0.002-30%0.007-145%0.022-114%0.021-115%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.650+54%
Intrinsic Value_10Y_max--1.929----------
Intrinsic Value_10Y_min--1.663----------
Intrinsic Value_1Y_max--0.174----------
Intrinsic Value_1Y_min--0.171----------
Intrinsic Value_3Y_max--0.538----------
Intrinsic Value_3Y_min--0.513----------
Intrinsic Value_5Y_max--0.919----------
Intrinsic Value_5Y_min--0.852----------
Market Cap3191322487.360+2%3138519661.9802743317002.125+14%3548572849.145-12%3494669036.797-10%4200038052.062-25%4860743993.703-35%
Net Profit Margin---0.099-0.139+41%-0.230+133%-0.152+54%-0.107+9%-0.033-67%
Operating Margin----0%-0.0370%-0.0530%-0.0090%0.007-100%
Operating Ratio--1.6851.404+20%1.443+17%1.351+25%1.325+27%1.075+57%
Pb Ratio11.595+2%11.4039.564+19%29.346-61%27.501-59%33.768-66%-452.466+4068%
Pe Ratio-359.605-2%-353.655-9897.359+2699%-83.837-76%-3368.400+852%-1720.968+387%-881.578+149%
Price Per Share9.670+2%9.5108.313+14%10.753-12%10.589-10%12.727-25%14.729-35%
Price To Free Cash Flow Ratio-758.263-2%-745.717-205.319-72%50.605-1574%-138.281-81%4.882-15375%27.426-2819%
Price To Total Gains Ratio-495.485-2%-487.286-147.346-70%262.531-286%346.313-241%1733.359-128%92.669-626%
Quick Ratio--0.5090.662-23%0.469+8%0.524-3%0.506+1%0.321+59%
Return On Assets---0.004-0.008+119%-0.009+151%-0.008+117%-0.006+50%0.002-254%
Return On Equity---0.009-0.020+113%-0.229+2328%-0.176+1765%-0.144+1421%0.157-106%
Total Gains Per Share---0.020-0.017-14%0.177-111%0.048-141%0.029-167%0.027-173%
Usd Book Value--38423905.67540178268.017-4%26703994.206+44%26864608.229+43%23000163.728+67%16138544.935+138%
Usd Book Value Change Per Share---0.003-0.003-2%0.023-112%0.006-148%0.003-184%0.003-201%
Usd Book Value Per Share--0.1160.122-4%0.081+44%0.081+43%0.070+67%0.049+138%
Usd Dividend Per Share--0.0000.000-71%0.001-90%0.001-81%0.001-79%0.001-85%
Usd Enterprise Value--392533935.705339952975.166+15%435688738.361-10%431832587.483-9%529927474.502-26%636097079.741-38%
Usd Eps---0.001-0.002+117%-0.003+226%-0.002+137%-0.002+63%0.000-67%
Usd Free Cash Flow---146884.645-339512.140+131%921815.601-116%1966183.347-107%216948.740-168%158036.204-193%
Usd Free Cash Flow Per Share--0.000-0.001+131%0.003-116%0.006-107%0.001-168%0.001-163%
Usd Free Cash Flow To Equity Per Share--0.000-0.001+131%0.000-30%0.001-145%0.003-114%0.003-115%
Usd Market Cap445508619.235+2%438137344.812382967053.497+14%495380769.741-12%487855797.537-10%586325312.068-25%678559861.521-35%
Usd Price Per Share1.350+2%1.3281.160+14%1.501-12%1.478-10%1.777-25%2.056-35%
Usd Profit---309721.063-673360.498+117%-1010956.465+226%-733969.761+137%-504677.667+63%-61184.527-80%
Usd Revenue--3134519.2494569370.394-31%4468079.724-30%4993249.087-37%5637842.122-44%4063758.034-23%
Usd Total Gains Per Share---0.003-0.002-14%0.025-111%0.007-141%0.004-167%0.004-173%
 EOD+5 -3MRQTTM+18 -19YOY+18 -193Y+16 -215Y+17 -2010Y+10 -29

3.3 Fundamental Score

Let's check the fundamental score of Nanhua Bio Medicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-359.605
Price to Book Ratio (EOD)Between0-111.595
Net Profit Margin (MRQ)Greater than0-0.099
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.509
Current Ratio (MRQ)Greater than11.280
Debt to Asset Ratio (MRQ)Less than10.543
Debt to Equity Ratio (MRQ)Less than11.391
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.004
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Nanhua Bio Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.462
Ma 20Greater thanMa 508.983
Ma 50Greater thanMa 1007.671
Ma 100Greater thanMa 2008.650
OpenGreater thanClose9.930
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Nanhua Bio Medicine Co Ltd

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. The company operates through Biomedicine, and Energy Saving and Environmental Protection segments. The Biomedicine segment engages in the provision of stem cell storage and technical services; stem cell therapy research; medical device procurement and sales, etc. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was founded in 1991 and is based in Changsha, China.

Fundamental data was last updated by Penke on 2025-06-21 12:41:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Nanhua Bio Medicine Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -9.9% means that ¥-0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is -9.9%. The company is making a loss. -1
  • The TTM is -13.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.9%TTM-13.9%+4.0%
TTM-13.9%YOY-23.0%+9.1%
TTM-13.9%5Y-10.7%-3.2%
5Y-10.7%10Y-3.3%-7.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.9%-91.7%+81.8%
TTM-13.9%-139.0%+125.1%
YOY-23.0%-194.4%+171.4%
3Y-15.2%-248.5%+233.3%
5Y-10.7%-343.3%+332.6%
10Y-3.3%-488.9%+485.6%
4.3.1.2. Return on Assets

Shows how efficient Nanhua Bio Medicine Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • -0.4% Return on Assets means that Nanhua Bio Medicine Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is -0.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.8%+0.4%
TTM-0.8%YOY-0.9%+0.1%
TTM-0.8%5Y-0.6%-0.3%
5Y-0.6%10Y0.2%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-11.6%+11.2%
TTM-0.8%-11.7%+10.9%
YOY-0.9%-11.4%+10.5%
3Y-0.8%-11.9%+11.1%
5Y-0.6%-12.0%+11.4%
10Y0.2%-13.8%+14.0%
4.3.1.3. Return on Equity

Shows how efficient Nanhua Bio Medicine Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • -0.9% Return on Equity means Nanhua Bio Medicine Co Ltd generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-2.0%+1.1%
TTM-2.0%YOY-22.9%+20.9%
TTM-2.0%5Y-14.4%+12.4%
5Y-14.4%10Y15.7%-30.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-13.5%+12.6%
TTM-2.0%-15.0%+13.0%
YOY-22.9%-14.5%-8.4%
3Y-17.6%-16.9%-0.7%
5Y-14.4%-17.7%+3.3%
10Y15.7%-19.9%+35.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Nanhua Bio Medicine Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Nanhua Bio Medicine Co Ltd is operating .

  • Measures how much profit Nanhua Bio Medicine Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.7%+3.7%
TTM-5Y-0.9%+0.9%
5Y-0.9%10Y0.7%-1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.3%+250.3%
YOY-3.7%-208.4%+204.7%
3Y-5.3%-221.7%+216.4%
5Y-0.9%-344.1%+343.2%
10Y0.7%-470.4%+471.1%
4.3.2.2. Operating Ratio

Measures how efficient Nanhua Bio Medicine Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are ¥1.68 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is 1.685. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.404. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.685TTM1.404+0.281
TTM1.404YOY1.443-0.039
TTM1.4045Y1.325+0.079
5Y1.32510Y1.075+0.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6852.108-0.423
TTM1.4042.680-1.276
YOY1.4433.080-1.637
3Y1.3513.621-2.270
5Y1.3254.734-3.409
10Y1.0756.546-5.471
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Nanhua Bio Medicine Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Nanhua Bio Medicine Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.28 means the company has ¥1.28 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is 1.280. The company is just able to pay all its short-term debts.
  • The TTM is 1.537. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.280TTM1.537-0.257
TTM1.537YOY1.250+0.287
TTM1.5375Y1.181+0.356
5Y1.18110Y0.687+0.493
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2803.616-2.336
TTM1.5373.826-2.289
YOY1.2504.141-2.891
3Y1.2474.661-3.414
5Y1.1815.756-4.575
10Y0.6876.149-5.462
4.4.3.2. Quick Ratio

Measures if Nanhua Bio Medicine Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.51 means the company can pay off ¥0.51 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is 0.509. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.662. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.509TTM0.662-0.153
TTM0.662YOY0.469+0.193
TTM0.6625Y0.506+0.156
5Y0.50610Y0.321+0.186
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5092.799-2.290
TTM0.6623.143-2.481
YOY0.4693.794-3.325
3Y0.5244.307-3.783
5Y0.5065.707-5.201
10Y0.3216.457-6.136
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Nanhua Bio Medicine Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Nanhua Bio Medicine Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nanhua Bio Medicine Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.54 means that Nanhua Bio Medicine Co Ltd assets are financed with 54.3% credit (debt) and the remaining percentage (100% - 54.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is 0.543. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.517. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.543TTM0.517+0.026
TTM0.517YOY0.705-0.188
TTM0.5175Y0.707-0.190
5Y0.70710Y0.772-0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5430.327+0.216
TTM0.5170.348+0.169
YOY0.7050.327+0.378
3Y0.6830.340+0.343
5Y0.7070.349+0.358
10Y0.7720.379+0.393
4.5.4.2. Debt to Equity Ratio

Measures if Nanhua Bio Medicine Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 139.1% means that company has ¥1.39 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The MRQ is 1.391. The company is able to pay all its debts with equity. +1
  • The TTM is 1.275. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.391TTM1.275+0.116
TTM1.275YOY33.615-32.340
TTM1.2755Y21.835-20.561
5Y21.83510Y74.227-52.392
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3910.379+1.012
TTM1.2750.435+0.840
YOY33.6150.412+33.203
3Y22.1440.448+21.696
5Y21.8350.460+21.375
10Y74.2270.509+73.718
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Nanhua Bio Medicine Co Ltd generates.

  • Above 15 is considered overpriced but always compare Nanhua Bio Medicine Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -353.65 means the investor is paying ¥-353.65 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The EOD is -359.605. Based on the earnings, the company is expensive. -2
  • The MRQ is -353.655. Based on the earnings, the company is expensive. -2
  • The TTM is -9,897.359. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-359.605MRQ-353.655-5.950
MRQ-353.655TTM-9,897.359+9,543.704
TTM-9,897.359YOY-83.837-9,813.522
TTM-9,897.3595Y-1,720.968-8,176.391
5Y-1,720.96810Y-881.578-839.389
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-359.605-2.303-357.302
MRQ-353.655-2.062-351.593
TTM-9,897.359-2.541-9,894.818
YOY-83.837-3.741-80.096
3Y-3,368.400-3.754-3,364.646
5Y-1,720.968-6.136-1,714.832
10Y-881.578-6.686-874.892
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The EOD is -758.263. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -745.717. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -205.319. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-758.263MRQ-745.717-12.546
MRQ-745.717TTM-205.319-540.398
TTM-205.319YOY50.605-255.925
TTM-205.3195Y4.882-210.201
5Y4.88210Y27.426-22.544
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-758.263-3.178-755.085
MRQ-745.717-2.700-743.017
TTM-205.319-3.619-201.700
YOY50.605-4.357+54.962
3Y-138.281-5.065-133.216
5Y4.882-8.478+13.360
10Y27.426-9.275+36.701
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Nanhua Bio Medicine Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 11.40 means the investor is paying ¥11.40 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Nanhua Bio Medicine Co Ltd:

  • The EOD is 11.595. Based on the equity, the company is expensive. -2
  • The MRQ is 11.403. Based on the equity, the company is expensive. -2
  • The TTM is 9.564. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.595MRQ11.403+0.192
MRQ11.403TTM9.564+1.839
TTM9.564YOY29.346-19.782
TTM9.5645Y33.768-24.205
5Y33.76810Y-452.466+486.234
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD11.5951.963+9.632
MRQ11.4031.848+9.555
TTM9.5642.119+7.445
YOY29.3462.469+26.877
3Y27.5012.526+24.975
5Y33.7683.664+30.104
10Y-452.4664.351-456.817
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets601,915
Total Liabilities326,672
Total Stockholder Equity234,877
 As reported
Total Liabilities 326,672
Total Stockholder Equity+ 234,877
Total Assets = 601,915

Assets

Total Assets601,915
Total Current Assets389,870
Long-term Assets212,044
Total Current Assets
Cash And Cash Equivalents 141,406
Short-term Investments 30,447
Net Receivables 124,634
Inventory 21,887
Other Current Assets 47,263
Total Current Assets  (as reported)389,870
Total Current Assets  (calculated)365,636
+/- 24,234
Long-term Assets
Property Plant Equipment 24,677
Goodwill 1,983
Intangible Assets 2,945
Long-term Assets Other 102
Long-term Assets  (as reported)212,044
Long-term Assets  (calculated)29,707
+/- 182,338

Liabilities & Shareholders' Equity

Total Current Liabilities304,625
Long-term Liabilities22,047
Total Stockholder Equity234,877
Total Current Liabilities
Accounts payable 86,625
Other Current Liabilities 14,298
Total Current Liabilities  (as reported)304,625
Total Current Liabilities  (calculated)100,922
+/- 203,703
Long-term Liabilities
Long term Debt 8,500
Capital Lease Obligations Min Short Term Debt12,366
Long-term Liabilities  (as reported)22,047
Long-term Liabilities  (calculated)20,866
+/- 1,181
Total Stockholder Equity
Total Stockholder Equity (as reported)234,877
Total Stockholder Equity (calculated)0
+/- 234,877
Other
Capital Stock330,023
Common Stock Shares Outstanding 330,023
Net Invested Capital 243,377
Net Working Capital 85,245
Property Plant and Equipment Gross 24,677



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
428,800
597,049
649,231
600,983
573,435
594,918
617,504
620,072
632,311
602,417
590,729
595,751
607,172
602,493
568,633
603,885
624,490
636,037
656,479
648,023
658,255
610,573
625,996
637,478
624,147
663,782
686,213
681,311
660,014
661,907
714,909
536,523
593,366
557,796
557,237
412,425
401,344
412,489
391,651
286,824
286,163
284,887
284,655
276,473
259,574
262,205
260,551
76,060
65,051
62,356
60,678
125,895
114,355
96,891
95,736
106,632
99,463
92,508
110,818
122,757
116,392
106,005
83,541
301,187
299,956
329,922
302,450
404,776
414,385
394,130
385,907
0
360,973
354,870
343,793
268,331
237,531
236,258
386,581
556,140
553,921
595,864
610,433
659,246
651,602
562,260
596,010
553,065
554,427
550,658
542,188
771,383
611,303
579,563
594,087
608,170
601,915
601,915608,170594,087579,563611,303771,383542,188550,658554,427553,065596,010562,260651,602659,246610,433595,864553,921556,140386,581236,258237,531268,331343,793354,870360,9730385,907394,130414,385404,776302,450329,922299,956301,18783,541106,005116,392122,757110,81892,50899,463106,63295,73696,891114,355125,89560,67862,35665,05176,060260,551262,205259,574276,473284,655284,887286,163286,824391,651412,489401,344412,425557,237557,796593,366536,523714,909661,907660,014681,311686,213663,782624,147637,478625,996610,573658,255648,023656,479636,037624,490603,885568,633602,493607,172595,751590,729602,417632,311620,072617,504594,918573,435600,983649,231597,049428,800
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167,348
165,369
164,034
143,586
114,394
125,891
286,909
479,701
474,948
492,618
502,409
516,623
510,547
421,395
457,679
416,236
420,281
419,314
419,449
654,851
497,830
472,210
492,882
401,904
389,870
389,870401,904492,882472,210497,830654,851419,449419,314420,281416,236457,679421,395510,547516,623502,409492,618474,948479,701286,909125,891114,394143,586164,034165,369167,348000000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,396
82,803
57,371
69,391
16,533
44,859
148,679
67,038
78,865
82,631
99,438
153,005
155,965
160,051
188,825
218,148
205,071
217,507
218,260
493,811
212,628
204,540
214,738
207,363
141,406
141,406207,363214,738204,540212,628493,811218,260217,507205,071218,148188,825160,051155,965153,00599,43882,63178,86567,038148,67944,85916,53369,39157,37182,80373,396000000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,274
1,050
985
962
897
700
880
657
590
555
540
502
1,161
4,225
10,613
1,685
10,670
1,603
1,471
1,718
100,526
102,446
100,533
608
30,447
30,447608100,533102,446100,5261,7181,4711,60310,6701,68510,6134,2251,1615025405555906578807008979629851,0501,274000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
51,484
146,213
137,109
105,947
0
135,525
146,693
127,488
134,135
134,212
135,909
138,400
138,421
139,576
145,028
174,289
178,729
179,258
186,783
173,852
176,803
182,960
186,406
186,754
188,280
119,192
142,753
114,906
134,666
122,535
141,665
130,132
161,103
118,994
118,251
91,789
86,593
94,383
98,113
58,327
59,706
62,119
65,021
41,781
43,685
46,784
48,354
33,403
24,528
23,967
22,006
18,521
17,815
16,966
15,970
8,866
7,955
8,340
11,384
9,805
6,024
7,327
7,054
51,790
46,700
14,818
16,946
32,340
31,333
26,009
24,414
0
30,669
34,697
39,532
52,691
51,839
59,029
111,856
222,492
224,098
239,557
247,804
202,219
179,609
203,116
203,885
186,426
168,248
190,767
183,861
123,224
124,167
124,635
129,217
139,582
124,634
124,634139,582129,217124,635124,167123,224183,861190,767168,248186,426203,885203,116179,609202,219247,804239,557224,098222,492111,85659,02951,83952,69139,53234,69730,669024,41426,00931,33332,34016,94614,81846,70051,7907,0547,3276,0249,80511,3848,3407,9558,86615,97016,96617,81518,52122,00623,96724,52833,40348,35446,78443,68541,78165,02162,11959,70658,32798,11394,38386,59391,789118,251118,994161,103130,132141,665122,535134,666114,906142,753119,192188,280186,754186,406182,960176,803173,852186,783179,258178,729174,289145,028139,576138,421138,400135,909134,212134,135127,488146,693135,5250105,947137,109146,21351,484
       Other Current Assets 
1,436
1,523
3,490
1,972
178,358
1,658
2,194
1,513
4,823
2,552
1,489
4,867
4,093
2,045
1,154
2,194
4,244
3,258
2,029
888
400
371
1,212
5,885
1,291
1,056
1,296
4,595
4,941
1,256
1,279
959
1,068
927
894
1,250
1,264
2,050
1,777
795
876
872
837
1,302
1,083
1,270
1,271
107
107
104
141
101
535
109
109
274
288
340
8,861
4,282
8,350
8,459
9,788
6,709
26,603
6,263
85,499
1,643
13,675
2,845
50,148
0
19,662
4,245
22,031
1,727
27,237
3,098
7,583
174,516
156,110
157,316
142,051
150,258
163,309
43,291
43,639
5,442
4,071
3,438
8,584
7,229
23,453
7,886
8,418
12,014
47,263
47,26312,0148,4187,88623,4537,2298,5843,4384,0715,44243,63943,291163,309150,258142,051157,316156,110174,5167,5833,09827,2371,72722,0314,24519,662050,1482,84513,6751,64385,4996,26326,6036,7099,7888,4598,3504,2828,8613402882741091095351011411041071071,2711,2701,0831,3028378728767951,7772,0501,2641,2508949271,0689591,2791,2564,9414,5951,2961,0561,2915,8851,2123714008882,0293,2584,2442,1941,1542,0454,0934,8671,4892,5524,8231,5132,1941,658178,3581,9723,4901,5231,436
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,625
189,501
179,758
124,745
123,137
110,367
99,673
76,439
78,973
103,246
108,024
142,622
141,055
140,865
138,331
136,829
134,146
131,344
122,739
116,531
113,472
107,353
101,205
206,266
212,044
212,044206,266101,205107,353113,472116,531122,739131,344134,146136,829138,331140,865141,055142,622108,024103,24678,97376,43999,673110,367123,137124,745179,758189,501193,625000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
158,635
124,181
118,601
22,813
0
21,569
44,379
43,300
68,663
69,261
71,741
64,383
63,918
63,590
63,242
63,002
62,815
70,797
61,009
69,547
60,092
74,993
67,267
72,985
65,073
72,189
63,631
29,507
21,228
29,207
20,823
28,080
19,799
27,250
18,945
18,848
18,442
18,057
17,794
24,062
23,926
23,662
23,515
23,735
23,372
23,034
22,673
3,234
3,145
3,053
2,962
56,797
56,295
55,811
55,309
53,224
52,268
51,379
50,441
36,372
35,660
34,969
34,273
12,730
12,464
12,270
12,091
11,953
16,287
17,793
18,479
20,668
20,187
20,141
20,033
11,655
11,436
11,282
11,137
11,595
15,494
31,429
36,204
35,854
38,001
37,569
35,831
35,934
35,083
34,510
28,008
28,060
27,155
25,798
25,040
26,055
24,677
24,67726,05525,04025,79827,15528,06028,00834,51035,08335,93435,83137,56938,00135,85436,20431,42915,49411,59511,13711,28211,43611,65520,03320,14120,18720,66818,47917,79316,28711,95312,09112,27012,46412,73034,27334,96935,66036,37250,44151,37952,26853,22455,30955,81156,29556,7972,9623,0533,1453,23422,67323,03423,37223,73523,51523,66223,92624,06217,79418,05718,44218,84818,94527,25019,79928,08020,82329,20721,22829,50763,63172,18965,07372,98567,26774,99360,09269,54761,00970,79762,81563,00263,24263,59063,91864,38371,74169,26168,66343,30044,37921,569022,813118,601124,181158,635
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,152
23,152
23,152
23,152
23,152
57,583
57,583
57,583
0
51,185
51,185
51,185
11,231
11,231
11,231
11,231
11,231
11,231
11,231
11,231
8,441
8,461
8,441
8,441
8,441
8,441
8,441
8,441
1,983
1,983
1,983
1,983
1,983
1,983
1,9831,9831,9831,9831,9831,9838,4418,4418,4418,4418,4418,4418,4618,44111,23111,23111,23111,23111,23111,23111,23111,23151,18551,18551,185057,58357,58357,58323,15223,15223,15223,15223,152000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
38,797
39,165
0
38,798
20,893
20,789
20,684
9,223
9,167
9,111
9,054
8,998
8,941
8,885
8,829
455
8,716
8,660
8,603
385
8,490
611
236,641
387,906
339,199
103,229
341,129
387,940
340,960
27,885
238,652
83,811
238,479
0
187,718
0
180,256
0
178,749
0
178,498
0
178,468
0
178,272
0
28,192
0
27,756
0
22,118
21,958
21,777
17,450
17,269
17,087
16,907
14,496
14,297
13,864
13,666
32,059
31,747
31,425
31,104
30,860
76,325
75,693
75,060
0
17,001
13,434
15,646
2,908
2,564
2,220
1,875
1,544
1,384
1,082
750
218
293
300
317
361
350
469
455
441
427
413
398
1,857
2,945
2,9451,8573984134274414554693503613173002932187501,0821,3841,5441,8752,2202,5642,90815,64613,43417,001075,06075,69376,32530,86031,10431,42531,74732,05913,66613,86414,29714,49616,90717,08717,26917,45021,77721,95822,118027,756028,1920178,2720178,4680178,4980178,7490180,2560187,7180238,47983,811238,65227,885340,960387,940341,129103,229339,199387,906236,6416118,4903858,6038,6608,7164558,8298,8858,9418,9989,0549,1119,1679,22320,68420,78920,89338,798039,16538,79700
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,625
189,501
179,758
73
123,137
0
11,137
3,363
3,312
1,900
1,900
1,509
68
2,328
68
645
629
259
59
38
38
38
38
705
102
1027053838383859259629645682,328681,5091,9001,9003,3123,36311,1370123,13773179,758189,501193,625000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
275,641
211,300
259,625
278,693
251,019
266,916
276,501
232,774
237,746
202,869
182,006
172,251
181,413
178,791
138,547
160,030
179,441
186,920
203,623
202,165
212,074
161,099
178,570
193,702
177,401
215,827
239,515
232,310
210,691
226,226
283,115
258,363
318,848
291,081
295,208
267,946
251,570
267,426
243,372
125,690
126,759
126,319
126,659
146,093
129,231
132,610
133,991
96,863
93,643
96,700
97,334
122,324
115,646
91,958
95,077
99,605
96,315
92,915
114,330
137,263
135,611
133,174
113,913
221,430
226,074
265,421
246,271
276,344
275,524
263,435
263,351
0
259,999
263,141
258,008
153,875
123,637
116,685
266,007
421,659
417,778
466,879
481,718
548,926
544,520
448,064
477,531
473,181
474,105
476,595
457,594
466,709
309,475
286,768
292,883
326,172
326,672
326,672326,172292,883286,768309,475466,709457,594476,595474,105473,181477,531448,064544,520548,926481,718466,879417,778421,659266,007116,685123,637153,875258,008263,141259,9990263,351263,435275,524276,344246,271265,421226,074221,430113,913133,174135,611137,263114,33092,91596,31599,60595,07791,958115,646122,32497,33496,70093,64396,863133,991132,610129,231146,093126,659126,319126,759125,690243,372267,426251,570267,946295,208291,081318,848258,363283,115226,226210,691232,310239,515215,827177,401193,702178,570161,099212,074202,165203,623186,920179,441160,030138,547178,791181,413172,251182,006202,869237,746232,774276,501266,916251,019278,693259,625211,300275,641
   > Total Current Liabilities 
274,641
210,300
258,625
257,272
229,598
245,495
255,079
231,774
236,746
201,868
181,006
171,251
180,413
177,791
137,546
158,530
177,942
185,420
202,124
200,665
210,574
159,400
176,949
192,112
162,004
214,250
237,943
230,493
208,874
224,649
281,539
256,863
317,348
289,581
293,708
266,445
250,070
265,926
241,872
124,190
125,259
124,819
125,159
144,593
127,731
131,110
132,491
95,363
92,143
95,200
95,834
113,799
107,121
83,784
87,079
98,105
94,815
91,415
112,830
135,763
134,111
131,674
112,413
216,166
220,811
260,157
241,007
251,982
249,368
238,294
238,445
0
251,728
255,073
250,119
149,605
119,591
112,858
262,395
418,261
414,594
445,140
460,775
529,002
523,443
430,191
457,659
455,152
456,123
461,289
440,505
452,397
294,377
274,538
269,113
305,471
304,625
304,625305,471269,113274,538294,377452,397440,505461,289456,123455,152457,659430,191523,443529,002460,775445,140414,594418,261262,395112,858119,591149,605250,119255,073251,7280238,445238,294249,368251,982241,007260,157220,811216,166112,413131,674134,111135,763112,83091,41594,81598,10587,07983,784107,121113,79995,83495,20092,14395,363132,491131,110127,731144,593125,159124,819125,259124,190241,872265,926250,070266,445293,708289,581317,348256,863281,539224,649208,874230,493237,943214,250162,004192,112176,949159,400210,574200,665202,124185,420177,942158,530137,546177,791180,413171,251181,006201,868236,746231,774255,079245,495229,598257,272258,625210,300274,641
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140,000
140,000
140,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000140,000140,000140,000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140,000
140,000
140,000
50,078
20,031
20,028
30,042
13,015
30,042
48,054
45,059
32,910
55,080
43,052
62,967
63,083
61,084
58,123
38,127
28,117
28,111
0
0
0
0
000028,11128,11738,12758,12361,08463,08362,96743,05255,08032,91045,05948,05430,04213,01530,04220,02820,03150,078140,000140,000140,000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
5,199
36,882
29,752
41,880
0
40,256
26,738
21,153
29,516
21,702
21,942
21,782
21,760
20,021
19,992
20,540
19,730
19,445
21,836
21,776
16,842
16,821
17,949
17,726
0
31,981
40,669
35,550
40,323
82,572
100,619
57,167
119,139
119,761
135,746
104,487
56,744
60,263
57,059
10,564
10,565
11,379
13,346
13,425
13,519
16,814
18,182
15,493
12,699
14,787
14,865
13,940
9,450
9,372
11,490
10,033
8,794
9,936
11,044
10,105
8,660
8,596
10,617
33,172
26,816
30,254
31,892
35,354
29,345
33,845
30,993
0
26,808
24,527
24,892
15,621
16,058
14,720
46,460
60,692
53,262
51,023
51,215
89,562
94,928
91,924
91,712
82,032
82,245
80,783
79,564
82,213
79,461
80,414
70,563
84,466
86,625
86,62584,46670,56380,41479,46182,21379,56480,78382,24582,03291,71291,92494,92889,56251,21551,02353,26260,69246,46014,72016,05815,62124,89224,52726,808030,99333,84529,34535,35431,89230,25426,81633,17210,6178,5968,66010,10511,0449,9368,79410,03311,4909,3729,45013,94014,86514,78712,69915,49318,18216,81413,51913,42513,34611,37910,56510,56457,05960,26356,744104,487135,746119,761119,13957,167100,61982,57240,32335,55040,66931,981017,72617,94916,82116,84221,77621,83619,44519,73020,54019,99220,02121,76021,78221,94221,70229,51621,15326,73840,256041,88029,75236,8825,199
       Other Current Liabilities 
145,827
114,779
120,234
81,883
229,598
76,730
82,832
25,112
21,731
24,667
23,555
18,960
18,144
17,261
17,045
17,481
17,703
15,466
15,779
14,380
14,223
13,070
13,491
14,877
18,495
18,760
22,765
24,943
44,551
62,077
62,920
81,696
80,209
81,820
87,962
118,958
140,326
205,663
184,813
113,626
114,694
113,440
111,813
116,168
114,212
114,296
114,309
79,870
79,444
80,413
80,969
99,859
97,670
66,819
75,588
74,285
86,021
68,115
81,786
72,541
75,450
69,898
71,796
25,773
58,395
12,919
7,123
20,847
18,040
27,165
57,453
0
19,000
18,500
8,500
51,232
43,640
46,912
183,572
75,764
70,247
80,366
93,646
398,011
107,933
125,725
134,412
142,968
146,932
156,146
158,909
11,497
13,377
12,520
12,752
13,880
14,298
14,29813,88012,75212,52013,37711,497158,909156,146146,932142,968134,412125,725107,933398,01193,64680,36670,24775,764183,57246,91243,64051,2328,50018,50019,000057,45327,16518,04020,8477,12312,91958,39525,77371,79669,89875,45072,54181,78668,11586,02174,28575,58866,81997,67099,85980,96980,41379,44479,870114,309114,296114,212116,168111,813113,440114,694113,626184,813205,663140,326118,95887,96281,82080,20981,69662,92062,07744,55124,94322,76518,76018,49514,87713,49113,07014,22314,38015,77915,46617,70317,48117,04517,26118,14418,96023,55524,66721,73125,11282,83276,730229,59881,883120,234114,779145,827
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,272
8,069
7,888
4,270
4,045
3,827
3,611
3,397
3,184
21,738
20,943
19,924
21,077
17,873
19,871
18,029
17,981
15,306
17,089
14,312
15,098
12,231
23,770
20,701
22,047
22,04720,70123,77012,23115,09814,31217,08915,30617,98118,02919,87117,87321,07719,92420,94321,7383,1843,3973,6113,8274,0454,2707,8888,0698,272000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-140,000
-140,000
-140,000
0
0
0
0
0
0
18,728
18,106
16,886
18,120
15,034
17,132
14,789
16,191
13,597
15,455
13,003
13,859
10,898
13,920
10,450
12,366
12,36610,45013,92010,89813,85913,00315,45513,59716,19114,78917,13215,03418,12016,88618,10618,728000000-140,000-140,000-140,000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
0
1,000
0
1,000
0
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,00001,00001,00001,000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,563
48,332
47,226
49,460
46,780
45,735
44,021
42,506
41,449
40,295
50,409
50,724
89,579
87,231
85,242
86,693
85,668
0
81,801
79,912
0
0
0
0
0
0
00000079,91281,801085,66886,69385,24287,23189,57950,72450,40940,29541,44942,50644,02145,73546,78049,46047,22648,33249,56300000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
141,919
314,973
311,755
322,290
322,416
328,001
341,004
387,298
388,151
393,148
402,360
419,152
421,434
419,430
425,803
439,605
440,813
444,869
448,660
441,659
441,998
445,323
443,278
443,776
446,746
447,955
446,698
449,000
449,322
435,682
431,794
278,160
274,518
266,715
262,029
142,604
147,052
142,166
145,271
156,169
154,492
153,606
153,008
126,266
126,196
125,433
122,457
0
0
0
0
1,055
0
2,536
0
4,709
900
0
0
0
0
0
0
5,273
375
0
0
24,643
17,359
9,192
1,763
0
-16,917
-24,857
-30,450
18,414
16,814
16,324
14,918
26,569
27,526
20,270
18,167
16,640
16,800
18,807
17,181
13,771
11,795
4,798
14,258
256,941
254,171
248,548
248,647
237,095
234,877
234,877237,095248,647248,548254,171256,94114,2584,79811,79513,77117,18118,80716,80016,64018,16720,27027,52626,56914,91816,32416,81418,414-30,450-24,857-16,91701,7639,19217,35924,643003755,2730000009004,70902,53601,0550000122,457125,433126,196126,266153,008153,606154,492156,169145,271142,166147,052142,604262,029266,715274,518278,160431,794435,682449,322449,000446,698447,955446,746443,776443,278445,323441,998441,659448,660444,869440,813439,605425,803419,430421,434419,152402,360393,148388,151387,298341,004328,001322,416322,290311,755314,973141,919
   Retained Earnings 
0
0
0
0
0
0
0
8,240
9,093
14,090
23,303
35,316
37,598
35,594
41,967
51,299
52,507
56,563
60,354
53,045
53,384
56,709
54,664
55,050
61,220
62,428
61,172
63,984
64,306
50,666
46,778
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-463,760
-504,852
-512,630
-518,394
-444,953
-446,553
-447,044
-448,449
-436,799
-435,842
-443,097
-445,200
-455,925
-455,765
-453,758
-455,384
-468,620
-505,141
-477,593
-468,133
-531,101
-533,871
-539,493
-546,904
-550,947
-553,165
-553,165-550,947-546,904-539,493-533,871-531,101-468,133-477,593-505,141-468,620-455,384-453,758-455,765-455,925-445,200-443,097-435,842-436,799-448,449-447,044-446,553-444,953-518,394-512,630-504,852-463,760000000000000000000000000000000000000000046,77850,66664,30663,98461,17262,42861,22055,05054,66456,70953,38453,04560,35456,56352,50751,29941,96735,59437,59835,31623,30314,0909,0938,2400000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue134,448
Cost of Revenue-43,808
Gross Profit90,64090,640
 
Operating Income (+$)
Gross Profit90,640
Operating Expense-136,481
Operating Income-2,034-45,842
 
Operating Expense (+$)
Research Development9,692
Selling General Administrative83,333
Selling And Marketing Expenses0
Operating Expense136,48193,025
 
Net Interest Income (+$)
Interest Income2,027
Interest Expense-1,462
Other Finance Cost-326
Net Interest Income239
 
Pretax Income (+$)
Operating Income-2,034
Net Interest Income239
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,852-2,034
EBIT - interestExpense = -1,462
-19,846
-18,384
Interest Expense1,462
Earnings Before Interest and Taxes (EBIT)0-19,389
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-20,852
Tax Provision-3,074
Net Income From Continuing Ops-23,926-23,926
Net Income-19,846
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-239
 

Technical Analysis of Nanhua Bio Medicine Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nanhua Bio Medicine Co Ltd. The general trend of Nanhua Bio Medicine Co Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nanhua Bio Medicine Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Nanhua Bio Medicine Co Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nanhua Bio Medicine Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 9.96 < 10.46 < 10.60.

The bearish price targets are: 9.44 > 9.23 > 7.33.

Know someone who trades $000504? Share this with them.👇

Nanhua Bio Medicine Co Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nanhua Bio Medicine Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nanhua Bio Medicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nanhua Bio Medicine Co Ltd. The current macd is 0.51732341.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nanhua Bio Medicine Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nanhua Bio Medicine Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nanhua Bio Medicine Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nanhua Bio Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNanhua Bio Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nanhua Bio Medicine Co Ltd. The current adx is 43.86.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nanhua Bio Medicine Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Nanhua Bio Medicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nanhua Bio Medicine Co Ltd. The current sar is 8.8778143.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nanhua Bio Medicine Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nanhua Bio Medicine Co Ltd. The current rsi is 66.46. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Nanhua Bio Medicine Co Ltd Daily Relative Strength Index (RSI) ChartNanhua Bio Medicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nanhua Bio Medicine Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nanhua Bio Medicine Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Nanhua Bio Medicine Co Ltd Daily Stochastic Oscillator ChartNanhua Bio Medicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nanhua Bio Medicine Co Ltd. The current cci is 154.00.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Nanhua Bio Medicine Co Ltd Daily Commodity Channel Index (CCI) ChartNanhua Bio Medicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nanhua Bio Medicine Co Ltd. The current cmo is 35.61.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nanhua Bio Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNanhua Bio Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nanhua Bio Medicine Co Ltd. The current willr is -28.30188679.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nanhua Bio Medicine Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Nanhua Bio Medicine Co Ltd Daily Williams %R ChartNanhua Bio Medicine Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nanhua Bio Medicine Co Ltd.

Nanhua Bio Medicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nanhua Bio Medicine Co Ltd. The current atr is 0.43024067.

Nanhua Bio Medicine Co Ltd Daily Average True Range (ATR) ChartNanhua Bio Medicine Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nanhua Bio Medicine Co Ltd. The current obv is 214,964,975.

Nanhua Bio Medicine Co Ltd Daily On-Balance Volume (OBV) ChartNanhua Bio Medicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nanhua Bio Medicine Co Ltd. The current mfi is 75.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Nanhua Bio Medicine Co Ltd Daily Money Flow Index (MFI) ChartNanhua Bio Medicine Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nanhua Bio Medicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-05-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Nanhua Bio Medicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nanhua Bio Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.462
Ma 20Greater thanMa 508.983
Ma 50Greater thanMa 1007.671
Ma 100Greater thanMa 2008.650
OpenGreater thanClose9.930
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Nanhua Bio Medicine Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Nanhua Bio Medicine Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nanhua Bio Medicine Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nanhua Bio Medicine Co Ltd

I send you an email if I find something interesting about Nanhua Bio Medicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nanhua Bio Medicine Co Ltd.

Receive notifications about Nanhua Bio Medicine Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.